In addition, Ibrahim et al. (2022) reported that the SGLT-2 inhibitor dapagliflozin directly phosphorylated LKB1, leading to increased hippocampal expression of p-AMPK in the ovariectomized/D-galactose rat model of Alzheimer’s disease. This evidence concerns the gene STK11 and early-onset autosomal dominant Alzheimer disease.